CARLEE LAPENSEE: Open Payments
NPI 1447572862 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,526 in 50 payments from 18 companies in 2025. Trend: 2023 $1,373 · 2024 $1,990 · 2025 $1,526
Food & beverage: $1,371Education: $155
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $311 |
| Botanix SB Inc | 3 | $165 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $164 |
| Organon LLC | 3 | $137 |
| Amgen Inc. | 5 | $109 |
| Janssen Biotech, Inc. | 3 | $98 |
| GENZYME CORPORATION | 3 | $82 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $67 |
| UCB, Inc. | 2 | $64 |
| PFIZER INC. | 2 | $57 |
Products named: SOFDRA, SKYRIZI, VTAMA, DUPIXENT, OTEZLA, TREMFYA, Bimzelx, ILUMYA.
Industry payments across FL — which companies pay providers there.
